Pro zobrazení tohoto obsahu je třeba být přihlášen.
Categories for Uncategorized
IS THE SPLENECTOMY OUTCOME PREDICTABLE IN PATIENTS WITH ITP?
15 októbra, 2020 7:26 pmAuthor(s): Mirjana Mitrovic, Slavko Matic, Jelena Bodrozic, et. al. Abstract: E1448 Session topic: 32. Platelets disorders Background:...
SAFETY AND EFFICACY OF LONG-TERM OPEN-LABEL DOSING OF SUBCUTANEOUS (SC) ROMIPLOSTIM IN CHILDREN WITH IMMUNE THROMBOCYTOPENIA (ITP)
15 októbra, 2020 7:26 pmAuthor(s): James Bussel, Michael Tarantino, Victor Blanchette, et. al. Abstract: P 727 Session topic: 32. Platelets disorders ...
TREATMENT OF PRIMARY ADULT CHRONIC IMMUNE THROMBOCYTOPENIA (CITP) WITH FOSTAMATINIB, AN ORAL SYK INHIBITOR: RESULTS OF TWO RANDOMIZED, PLACEBO-CONTROLLED PHASE 3 STUDIES
15 októbra, 2020 7:26 pmAuthor(s): J Bussel, J Mayer, L Cervinek, K Chojnowski, et. al. Abstract: S 435 Session topic: 32. Platelets...
REAL WORLD EVIDENCE ON DRUG UTILIZATION PATTERNS OF ELTROMBOPAG IN ADULT PATIENTS WITH IMMUNE THROMBOCYTOPENIA: REVIEU (REVOLADE™ [ELTROMBOPAG] IN SELECTED COUNTRIES IN THE EUROPEAN UNION) STUDY
15 októbra, 2020 7:25 pmAuthor(s): Emilio Ojeda Gutiérrez, Abdulgabar Salama, Jean-François Viallard, et. al. Abstract: P 720 Session topic: 32. Platelets disorders...
Optimalizácia liečby imúnnej trombocytopénie a nové stratégie liečby trombocytopénie pri aplastickej anémii a myelodysplastickom syndróme
15 októbra, 2020 7:25 pmNa tohtoročnom kongrese EHA odzneli viaceré prednášky na tému imúnnej trombocytopénie (ITP), jej patofyziológie, nových možností a optimalizácie jej liečby. ITP je získané...
PATIENTS WITH IDIOPATHIC CYTOPENIA OF UNDETERMINED SIGNIFICANCE SHOW SIMILAR SURVIVAL PATTERNS AS LOW RISK MDS PATIENTS
15 októbra, 2020 7:25 pmAuthor(s): Jakob Werner Hansen, Maj Westman, Andreas Due Orskov, et. al. Abstract: S 486 Session topic: 10. Myelodysplastic...
A PHASE IB STUDY EVALUATING THE SAFETY AND CLINICAL ACTIVITY OF ATEZOLIZUMAB ALONE AND IN COMBINATION WITH AZACITIDINE IN PATIENTS WITH RELAPSED OR REFRACTORY MYELODYSPLASTIC SYNDROMES
15 októbra, 2020 7:25 pmAuthor(s): Aaron T. Gerds, Bart L. Scott, Peter Greenberg, et. al. Abstract: P 662 Session topic: 10. Myelodysplastic...
DIFFERENTIAL DIAGNOSIS BETWEEN MYELODYSPLASTIC SYNDROMES AND NON-CLONAL CYTOPENIAS BY FLOW CYTOMETRY ANALYSIS USING A MYELOID MATURATION DATABASE
15 októbra, 2020 7:25 pmAuthor(s): M Teresa Cedena, Fátima Mirás, Rosa M Ayala, et. al Abstract: P 661 Session topic: 9. Myelodysplastic...
UPDATED RESULTS FROM PHASE 2 STUDY OF GUADECITABINE FOR PATIENTS WITH UNTREATED INT-2/HIGH RISK MYELODYSPLASTIC SYNDROMES OR CHRONIC MYELOMONOCYTIC LEUKEMIA
15 októbra, 2020 7:25 pmAuthor(s): Guillermo Montalban-Bravo, Prithviraj Bose, Yesid Alvarado, et. al. Abstract: P 315 Session topic: 10. Myelodysplastic syndromes –...
Myelodysplastický syndróm
15 októbra, 2020 7:25 pmAbstrakt: Myelodysplastický syndróm (MDS) predstavuje skupinu klonálnych myeloidných ochorení, je charakterizovaný dysplastickými zmenami a inefektívnou hematopoézou, ktorá vedie k periférnej cytopénii so...